Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Double radiation attack: new hope for Hard-to-Treat gut tumors?

NCT ID NCT07150546

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times

Summary

This early-phase study tests whether adding a precise, high-dose external radiation treatment (SBRT) before a standard radioactive drug therapy (177Lu-DOTATATE) is safe and works better for people with large, inoperable neuroendocrine tumors of the digestive system. About 15 adults whose tumors have grown despite prior treatments will receive both therapies. The main goal is to check for serious side effects, with a secondary focus on how well the tumors respond.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory University Hospital

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Email: •••••@•••••

    Contact

  • Emory University Hospital Midtown

    RECRUITING

    Atlanta, Georgia, 30308, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.